Stock Track | iRhythm Technologies Soars Over 5% in Pre-market on Strong Q4 Results and Upbeat 2025 Outlook

Stock Track02-21

iRhythm Technologies Inc. (IRTC) stock surged over 5% in pre-market trading on Friday, following the company's impressive fourth-quarter 2024 earnings results and a positive outlook for 2025. The leading digital healthcare company reported strong revenue growth and improving profitability in the fourth quarter, driven by sustained demand across all customer channels.

According to the earnings report, iRhythm Technologies achieved a 24% year-over-year increase in revenue to $164.3 million in Q4 2024. The company's gross margin improved to 70% by the end of the year, up from 66% at the beginning. Additionally, iRhythm reported its first positive adjusted net income in Q4 2024, marking a significant milestone in its journey towards profitable growth.

Looking ahead, iRhythm Technologies provided upbeat guidance for 2025, projecting revenue in the range of $675 million to $685 million and an adjusted EBITDA margin between 7% and 8%. The company celebrated the registration of its 1 millionth patient for its GeoMonitor service in 2024, highlighting the strong adoption of its long-term continuous monitoring solution. Furthermore, iRhythm expanded its international presence by launching services in several new markets and receiving regulatory approval in Japan.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1150536808?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2025-02-21 22:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1150536808","market":"hk","top_or_hot":-1,"title":"Stock Track | iRhythm Technologies Soars Over 5% in Pre-market on Strong Q4 Results and Upbeat 2025 Outlook","media":"Stock Track","content":"<p>iRhythm Technologies Inc. (IRTC) stock surged over 5% in pre-market trading on Friday, following the company's impressive fourth-quarter 2024 earnings results and a positive outlook for 2025. The leading digital healthcare company reported strong revenue growth and improving profitability in the fourth quarter, driven by sustained demand across all customer channels.</p>\n\n<p>According to the earnings report, iRhythm Technologies achieved a 24% year-over-year increase in revenue to $164.3 million in Q4 2024. The company's gross margin improved to 70% by the end of the year, up from 66% at the beginning. Additionally, iRhythm reported its first positive adjusted net income in Q4 2024, marking a significant milestone in its journey towards profitable growth.</p>\n\n<p>Looking ahead, iRhythm Technologies provided upbeat guidance for 2025, projecting revenue in the range of $675 million to $685 million and an adjusted EBITDA margin between 7% and 8%. The company celebrated the registration of its 1 millionth patient for its GeoMonitor service in 2024, highlighting the strong adoption of its long-term continuous monitoring solution. Furthermore, iRhythm expanded its international presence by launching services in several new markets and receiving regulatory approval in Japan.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | iRhythm Technologies Soars Over 5% in Pre-market on Strong Q4 Results and Upbeat 2025 Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | iRhythm Technologies Soars Over 5% in Pre-market on Strong Q4 Results and Upbeat 2025 Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-02-21 22:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>iRhythm Technologies Inc. (IRTC) stock surged over 5% in pre-market trading on Friday, following the company's impressive fourth-quarter 2024 earnings results and a positive outlook for 2025. The leading digital healthcare company reported strong revenue growth and improving profitability in the fourth quarter, driven by sustained demand across all customer channels.</p>\n\n<p>According to the earnings report, iRhythm Technologies achieved a 24% year-over-year increase in revenue to $164.3 million in Q4 2024. The company's gross margin improved to 70% by the end of the year, up from 66% at the beginning. Additionally, iRhythm reported its first positive adjusted net income in Q4 2024, marking a significant milestone in its journey towards profitable growth.</p>\n\n<p>Looking ahead, iRhythm Technologies provided upbeat guidance for 2025, projecting revenue in the range of $675 million to $685 million and an adjusted EBITDA margin between 7% and 8%. The company celebrated the registration of its 1 millionth patient for its GeoMonitor service in 2024, highlighting the strong adoption of its long-term continuous monitoring solution. Furthermore, iRhythm expanded its international presence by launching services in several new markets and receiving regulatory approval in Japan.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IRTC","symbol_name":"Irhythm Technologies Inc.","start_time":0,"source_url":"","article_id":"1150536808","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1150536808","pubTimestamp":1740148232,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"iRhythm Technologies Inc.  stock surged over 5% in pre-market trading on Friday, following the company's impressive fourth-quarter 2024 earnings results and a positive outlook for 2025. The leading digital healthcare company reported strong revenue growth and improving profitability in the fourth quarter, driven by sustained demand across all customer channels.According to the earnings report, iRhythm Technologies achieved a 24% year-over-year increase in revenue to $164.3 million in Q4 2024. Th","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IRTC":"Irhythm Technologies Inc."},"translate_title":"股票赛道iRhythm Technologies因强劲的第四季度业绩和乐观的2025年前景而盘前飙升超过5%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IRTC":1},"content_text":"iRhythm Technologies Inc. (IRTC) stock surged over 5% in pre-market trading on Friday, following the company's impressive fourth-quarter 2024 earnings results and a positive outlook for 2025. The leading digital healthcare company reported strong revenue growth and improving profitability in the fourth quarter, driven by sustained demand across all customer channels.\nAccording to the earnings report, iRhythm Technologies achieved a 24% year-over-year increase in revenue to $164.3 million in Q4 2024. The company's gross margin improved to 70% by the end of the year, up from 66% at the beginning. Additionally, iRhythm reported its first positive adjusted net income in Q4 2024, marking a significant milestone in its journey towards profitable growth.\nLooking ahead, iRhythm Technologies provided upbeat guidance for 2025, projecting revenue in the range of $675 million to $685 million and an adjusted EBITDA margin between 7% and 8%. The company celebrated the registration of its 1 millionth patient for its GeoMonitor service in 2024, highlighting the strong adoption of its long-term continuous monitoring solution. Furthermore, iRhythm expanded its international presence by launching services in several new markets and receiving regulatory approval in Japan.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1150536808"}